Fluoroestradiol F-18

Source: Wikipedia, the free encyclopedia.

Fluoroestradiol F-18
Clinical data
Trade namesCerianna
Other names[18F]16α-Fluoroestradiol; [18F]16α-Fluoroestra-1,3,5(10)-triene-3,17β-diol
License data
Diagnostic radiopharmaceutical
ATC code
Legal status
Legal status
Pharmacokinetic data
MetabolismLiver[1]
ExcretionGallbladder and kidney[1]
Identifiers
  • (8R,9S,13S,14S,16R,17R)-16-(18F)fluoranyl-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
JSmol)
  • CC12CCC3C(C1CC(C2O)[18F])CCC4=C3C=CC(=C4)O
  • InChI=1S/C18H23FO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1/i19-1
  • Key:KDLLNMRYZGUVMA-ZYMZXAKXSA-N

Fluoroestradiol F-18, also known as [18F]16α-fluoroestradiol and sold under the brand name Cerianna, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging.[1][2][3][4][5] It is an analog of estrogen and is used to detect estrogen receptor-positive breast cancer lesions.[1]

Chemistry

Chemically, fluoroestradiol F-18 is [18F]16α-fluoro-3,17β-diol-estratriene-1,3,5(10).[1]

History

Fluoroestradiol F-18 was approved for medical use in the United States in May 2020.[6]

See also

References

  1. ^ a b c d e f g "Cerianna- fluoroestradiol f 18 injection". DailyMed. 20 May 2020. Retrieved 24 September 2020.
  2. PMID 32229068
    .
  3. PMID 27774910
    .
  4. PMID 27307345
    .
  5. PMID 17920354
    .
  6. ^ "Cerianna: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 22 May 2020.

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Fluoroestradiol_F-18&oldid=1192768420"